Healthcare & Life Sciences
Convert Pharmaceuticals
Belgiumconvertpharma.com
Convert Pharmaceuticals is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Convert Pharmaceuticals
Based in Belgium, Convert Pharmaceuticals is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Convert Pharmaceuticals develops hypoxia-activated prodrugs that remain inactive until they reach tumor microenvironments, aiming to improve cancer treatment by targeting tumor hypoxia in various solid tumors.
Explore Convert Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.